The Use of Statistical Shape and Appearance Modelling for Predicting Osteoporotic Fracture Risk
Clinical Snapshot
PICO Framework
| P — Population | Patients at risk for osteoporotic fractures |
| I — Intervention | Statistical Shape and Appearance Modelling (SSAM) combined with computational analytics |
| C — Comparator | Traditional bone mineral density assessment methods |
| O — Outcomes | Fracture risk prediction accuracy, bone strength assessment |
Bottom Line
This narrative review examines Statistical Shape and Appearance Modelling (SSAM) as an emerging technology for osteoporotic fracture risk prediction. While SSAM shows promise in capturing detailed bone geometry and density patterns beyond traditional BMD measurements, the review lacks the systematic methodology expected of high-quality evidence synthesis. The authors acknowledge that clinical adoption remains limited by generalizability concerns. Although the technology may eventually enhance fracture risk assessment by incorporating 3D bone structure analysis with machine learning approaches, current evidence is insufficient to support routine clinical implementation. Clinicians should continue relying on established fracture risk assessment tools while monitoring developments in this field. Further systematic reviews with rigorous methodology and well-designed clinical validation studies are needed before SSAM can be recommended for clinical practice.
Key Findings
Effect Size: Not quantified
Primary Outcome: SSAM can capture detailed bone geometry and internal density distribution
Nnt Or Sensitivity: Not reported - narrative review without quantitative synthesis
Confidence Interval: Not reported
Clinical Application
Currently limited by generalizability issues and lack of standardized clinical protocols Potential relevance to PBS-funded bone density screening programs, but requires TGA approval and RACGP guideline integration before clinical implementation Patients requiring osteoporotic fracture risk assessment, particularly those with limitations in current BMD-based screening
Abstract
PURPOSE OF REVIEW: Osteoporotic fractures remain a major cause of morbidity and mortality worldwide. Current clinical assessment metrics (e.g., bone mineral density) are limited in their ability to identify fracture risk and bone strength. Statistical Shape and Appearance Modelling (SSAM) offers a method to quantify anatomical geometry and density patterns. This review examines advancements in SSAM for osteoporosis research. RECENT FINDINGS: Recent literature demonstrates that SSAM can capture detailed bone geometry and internal density distribution. Increasingly, these models are combined with computational analytics, including finite element analysis and machine learning, to assess the mechanical and structural behavior of bone. SSAM provides a robust quantitative framework for bone research. Notably, SSAM is used to reconstruct 3D subjects from clinical 2D images for biomechanical evaluation. Although clinical adoption remains limited by generalizability, the advancement of deep learning and complex SSAM pipelines supports its potential for osteoporosis screening and fracture risk prediction.
References
- 1.Chu, E. M., & Quenneville, C. E. (2026). The use of statistical shape and appearance modelling for predicting osteoporotic fracture risk. Current Osteoporosis Reports. https://doi.org/10.1007/s00198-020-05444-7
Related Research
European journal of radiology
A CT-based deep learning model to differentiate between benign and malignant adrenal lesions
3 Aug 2026
Journal of chemical information and modeling
A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation
28 July 2026
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis
23 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service